Rankings
▼
Calendar
SRPT FY 2024 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
SRPT
Sarepta Therapeutics, Inc.
$2B
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1.9B
+53.0% YoY
Gross Profit
$1.6B
83.2% margin
Operating Income
$218M
11.5% margin
Net Income
$235M
12.4% margin
EPS (Diluted)
$2.34
Cash Flow
Operating Cash Flow
-$206M
Free Cash Flow
-$353M
Stock-Based Comp.
$184M
Balance Sheet
Total Assets
$4.0B
Total Liabilities
$2.4B
Stockholders' Equity
$1.5B
Cash & Equivalents
$1.1B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.9B
$1.2B
+53.0%
Gross Profit
$1.6B
$1.1B
+44.8%
Operating Income
$218M
-$268M
+181.4%
Net Income
$235M
-$536M
+143.9%
← Q4 2023
All Quarters
Q1 2024 →